Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
Authors not listed
ECOG-ACRIN Cancer Research Group · 2026
Abstract
This phase III trial compares the effect of wide local excision (WLE) alone to usual care with WLE plus sentinel lymph node (SLN) biopsy for the treatment of older adults with early-stage melanoma. A WLE is a surgical procedure performed to cut out an abnormal lesion and some surrounding normal tissue. This is sometimes followed by a SLN biopsy, in which lymph nodes that tumor cells could spread to are removed as well. Using WLE alone may be just as effective as usual care in treating older adults with early-stage melanoma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Anonymous. (2026). A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients. <em>ECOG-ACRIN Cancer Research Group</em>. https://clinicaltrials.gov/study/NCT07068074
Vancouver
Anonymous. A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients. ECOG-ACRIN Cancer Research Group. 2026.
BibTeX
@misc{anon2026ARando,
title = {A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients},
author = {Anonymous},
journal = {ECOG-ACRIN Cancer Research Group},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pusan National University Yangsan Hospital 2021
Open access · US-GOV
Effect of Silkworms (Bombyx Mori L.) Pupae Extracts on Musculoskeletal Biomarkers in Adults With With Relatively Low Muscle Mass: a Randomized, Double-blinded, Placebo-controlled Trial
Fondazione EMN Italy Onlus 2014
Open access · US-GOV
A PHASE III, MULTICENTRE, RANDOMIZED, CONTROLLED STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
WestVac Biopharma Co., Ltd. 2021
Open access · US-GOV
A Global Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cells), for the Prevention of COVID-19 in Adults Aged 18 Years and Older
Seoul National University Bundang Hospital 2022
Open access · US-GOV
Effectiveness and Clinical Application of Multidisciplinary Combined Exercise and Nutrition Intervention for Sarcopenic Older Adults With Metabolic Syndrome: Multicenter Randomized Controlled Trial
Longeveron Inc. 2014
Open access · US-GOV
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
ENCell 2027
Open access · US-GOV